long-term the second will After on for for global quarter our everyone. targets. in thanks of will afternoon, we joining Good will progress an Rachel. call that, discuss open detail And Mark and results financial then growth your the our Today, you, questions. made our more us. overview financial Thank XXXX provide strategy. we've review I
building countries stages. global currently XX tens paradigm supported class a and a global aspire the packaged serves thousands do Tilray early supply with world still to that, multinational dollar its cannabis consumers shift a of in five to consumer company, And is be company. we're spanning goods brands continents. world's patients multibillion be by The platform of trusted of most to chain. to cannabis in We portfolio regard with a
We're in capital create scaled an creates a world shareholder way and be to the around that actions committed infrastructure can taking are order in long-term. the value to decisive deploying that over
to balance between equilibrium the Adult-use quarter the believe We're of pleased nearly be Harvest Canada quarter basis full sales. with from to and year-over-year our to supply included the could a increased XX demand. sold sequentially and million. revenue in quarter both kilograms. a million first of second equivalent XXX% Revenue quarter which US$XX with and total the on In second market finds revenue results, $XX.X as we kilograms first doubled year-over-year next increased X,XXX supply to XX there months, Manitoba an
enable While support the value LPs industry signed model improved on asset-light up further have and continues cultivation to have agreements our focus ramp the across performance chain and wholesale to supply production, long-term us cannabis seen downstream. the we to we
processing factors. Leamington, production new space manufacture investments production facility High space to this. High this regulations for investing of and topicals ready we're vapes, in edibles, Ontario. to including second adult-use capacity focused to production of The British the facility Columbia, Tilray’s ready High we've formats, be later US$XX.X new a phase to and strips, five are Park and support facilities with three Park beverages We increase products the The announced, And portfolio London million cannabis form cannabis of Gardens in brands expect the and oral the innovative Canada previously our our as as Ontario, year cannabis processing broad-based allow. Nanaimo, Canadian in on Park across is in
expansion other track. are The on two projects
export We our allows us export dried for Campus EU manufacture the license GMP in and for standard manufacturing certified have to Portugal products. certification that capacity expanded GMP international with and cannabis medicinal
We second particularly this of expect us which in Europe. additional enable scale international will markets, certifications to half to GMP year, in two the receive
our Just last cultivation in sophisticated the Definitive Agreement Esporão, of XX businesses international week, most Portugal. with we agreement of agricultural with and an increases additional our Portugal. Alentejo, also hectors largest space announced one in capacity This outdoor export
to harvest our manufacturing We distribution and materials international at other for site processing, transport then the medical dry cannabis will and EU across and grow, Europe new and Campus markets. it
of The is expected entire XXXX. successfully harvest outdoor cultivation site planted and in a was fall
ramp of significant growth we've a top already expect revenue in the strong on international We seen.
focused strategy that continues strong six performance business returns remains to grow. as expect Our global generate the top-line we drivers growth on to
increase to adult-use manufacturing as in over the market, capacity growing global well production and First, as market serve rapidly other medical and our time. Canada the markets
focus quality a rigorous as we on Second, maintain scale.
build Third, partner and that by and medical addressable products further a research diverse distribution pioneer the in appeal of and expand governments. with of with investing established patients mainstream portfolio faster. to fostering by and Fourth, a Fifth, the products consumers. differentiated and set innovation, medical and and development, future six, distributors retailers of community research. And of acceptance clinical scale market brands to the our industry our
accelerate and growth. We acquisitions expect our partnerships our strategic to
the for brands leveraging ABG year which with we launch The first Our its continues CBD build to of announced the States. half deal kind XX our market. the second in portfolio partnership more in of momentum with is a Authentic Group, partnership United first of strategic the ABG’s most of planned product global than Brands for QX iconic the world's
We InBev partnerships beverages. continue on with research on infused make AB cannabinoid our non-alcohol progress to
ready later in allow this be to as beverages regulations year. launch will Canada We
international large in with we on have half our market. markets, available the Sandoz we new working supply for depending to of add more pharmaceutical As countries and second companies other expect in-country this year additional the
Generally Hemp in the second in a we CBD U.S. Recognized the Manitoba year the Late Spectrum earlier in acquisition Tilray’s of Our launched is Manitoba the Safe marking this quarter, Harvest Broad entry opportunity an into as Harvest that line under U.S., brand. immense America. provides first market North Extract
we for leveraging starting thoroughly consistency a chain and all quality, execute tested are and are the Our products this have compliant. trusted in of taking hemp foods to of to asset safety and brand and thesis products against CBD supply We're our FDA ensured deliver products.
the acquired innovation. consumer infused July crafts for exciting brand CBD we acquisition & edible permit. On Sinclair, for the cocktails and portfolio United regulations focus in reflects XXth, expanding fragrances to with distribution This which States, also Tilray Smith on United our other enables disruptive and markets our develop Kingdom, known as edibles in brands candies,
will We long-term States to the our why global acquisitions of markets invest and cannabis two our opportunities for global partnerships the particularly growth. be focus global of the long-term, which United and our largest in expect demonstrate is our strategic markets. believe in We operations, for diversification those Europe we continue on
pursue research will we channels. factors, mergers provides that forward, opens new development and access brand capacity, to continue through our innovative Going to strategic brings acquisitions form increases territories, strategic our distribution technologies, us and offerings increases retail
industry we by acquisitions estimated such portfolio, With the Group, our building Our States to US$XX strategy to Manitoba as portfolio as Authentic on or via on will our be trusted brands. United a centered own capitalize our Sinclair, Harvest is brands. billion partnerships in foundation, hemp whether it derived as Brands to of such building continue Smith the add CBD &
will the United not Our is products any THC legal. in federally include it States until
hub Turning as operations. as be well to and Campus sites, The will export international mentioned earlier, have which EU packaging, products. for cultivation we as for Europe, labs, Portugal, with our international our distribution located I Cantanhede, includes our expanded outdoor facility processing, indoor, and sites research capacity medical in greenhouse
current shipping begun build to And phase we we the continue utilize of GMP have full year, of facility already manufacturing as later awaiting next under are will We some to the capacity our license. inventory. this products the our certification
we the currently demand of the approved with medical cannabis use supply a six supply. cannabis United Kingdom leading products. medical United have We medical imported up, second Kingdom. ramps oil quarter, well-positioned into the authorized are patients in to be solutions as for And locally maintained In we of provide products supplier to a wholesale
medical successfully this of year cannabis Ireland. The XXth certified Access is the medical that products. intended announced In Medical half finished in solutions July, Tilray oil we for makes under with solution country oil the we Cannabis second had cannabis Ireland cannabis This the imported nationwide The GMP in distribution Programme.
across indoor Additionally, Canada launch to research X space. Esporão number phase cultivation remains of a regulations as market of a in challenged I next with adds cultivation allow and supply manufacturing, lack hectors Campus’ the outdoor for we're cannabis Definitive retail and of and quality existing adult-use Agreement and XX mentioned processing our products meters X,XXX of excited Canadian the limited of outdoor earlier, of our outlets today. But of hectares mid-December. EU as square with The space
allows legalization more of deliver choose wave second we consumers formats, preferred possible the experiences. The best while of to their
In strips, to beverages. oral new topicals vapes, a and brands factors of High launching addition innovative cannabis including edibles, and number Park across various form
School NYU and mainstream Medicine in two quarter, medical from research in Disorder. to our and participation already patients successfully cannabis help field. new of of Tilray support Disorders announced approval Use received Stress two is believe last And Australia the with at led clinical governments. medical U.S. acceptance of In support at the for shipment the the announced a We just community need for by the serious with an clinical government of Post-Traumatic and we foster new imported clinical forefront the and U.S. we second trials in the more the week, clinical two will initial NYU. into Disorder And research industry. our cannabinoids There's we Alcohol within medical Alcohol data Use in studies trials Canada. the
balance in new transactions drive continuing we additional enter investment global anticipate and and For into strategic and growth. and clinical partnerships ones, continued will the enable of to year already us expansion XXXX, the trials that we serve in the markets
cannabis enable to a year; strategic shareholdings final initiating international partnerships and expanding sales further adding in markets and several the regions; expect additional further we the additional increasing before the to for end second close Ontario; processing our we added growth. finally, further obtaining we to currently announcing merger downstream additional that Highlights quarter; GMP added we facility and in strengthen anticipate during the half in we which Tilray from Park’s executives in agreement production two accelerate the facility third second and with two partnerships product of team, extending High our additional us quarter London, the quarter; in medical management and second and this year; in for certifications licenses the Portugal our and the and Nanaimo include: to Leamington of products offerings pharmaceutical countries to medical new our capacity serve; of countries Exporting clinical recruiting during private trials, obtaining Portugal the industry expanding our outside already
Now, execute to have I’m the over expect progress accelerate our I that on summary our before continues year. made in and back our all with growth strategic we call can half growth and of I on Mark, hand into next to team cylinders. initiatives, say this to firing the to-date the in pleased further year
can avenues have We and we long-term drive strong shareholder multiple growth for value. are confident
I would call like to Mark. the that, to With over turn